Jan Beyer-Westendorf

7PUBLICATIONS
43CO-AUTHORS
HaematologyMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromoleculesEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 07, 2026
Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical Trial.

|Apr 28, 2025
Association of Biomarkers With Intracerebral Hematoma Expansion and Arterial Thromboembolic Events in Patients With Acute Intracranial Hemorrhage: The ANNEXA-I Biomarker Substudy.

John W Eikelboom, Mukul Sharma, Lizhen Xu

|Nov 03, 2022
Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry.

Stephanie Müller, Luise Tittl, Victoria Speed

|Aug 22, 2022
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin.

Ingrid M Bistervels, Roisin Bavalia, Jan Beyer-Westendorf

|Dec 08, 2021
Cancer-Associated ThrOmboSIs - Patient-Reported OutcoMes With RivarOxaban (COSIMO) - Baseline characteristics and clinical outcomes.

Anthony Maraveyas, Jan Beyer-Westendorf, Agnes Y Lee

|Nov 11, 2021
Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC-MS/MS.

Lea Brückner, Jan Beyer-Westendorf, Oliver Tiebel

Pageof 2

Frequent Collaborators

2 joint publications

Anthony Maraveyas

2 joint publications

Per Ladenvall

2 joint publications

Francis Couturaud

2 joint publications

Mukul Sharma